| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000023227 |
| Receipt No. | R000024749 |
| Official scientific title of the study | Comparison of the lowering intraocular pressure after trabeculotomy between patients with and without response to Ripasudil. |
| Date of disclosure of the study information | 2016/07/20 |
| Last modified on | 2016/07/23 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Comparison of the lowering intraocular pressure after trabeculotomy between patients with and without response to Ripasudil. | |
| Title of the study (Brief title) | Trabeculotomy between patients with and without response to Ripasudil. | |
| Region |
|
|
| Condition | ||
| Condition | 1. Glaucoma
2. Ocular hypertention |
|
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Patients who respond to Ripasudil may have lower intraocular pressure(IOP) after trabeculotomy than those with no response, because the mechanism of elevated IOP is associate with main outflow tract in the patients who respond to Ripasudil. We will compare IOP levels between patients who respond to Ripasudil and patients who do not. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Intraocular pressure after trabeculotomy |
| Key secondary outcomes | Intraocular pressure 4 weeks after Ripasudil is initiated
C-value of tonography 4 weeks after Ripasudil is initiated C-value of tonography after trabeculotomy |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Self control |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Trabeculotomy 4 weeks after treatment with Ripasudil. | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patient with medically uncontrolled glaucoma who need trabeculotomy | |||
| Key exclusion criteria | Patients who don't agree with the treatment
Patients who need emergency glaucoma operation Patient who need trabeculectomy |
|||
| Target sample size | 40 | |||
| Research contact person | |
| Name of lead principal investigator | Chin Shinki |
| Organization | Hokkaido University Graduate School of Medicine |
| Division name | Department of Ophthalmology |
| Address | N-15, W-7, Kita-ku, Sapporo, Hokkaido, Japan |
| TEL | 011-706-5944 |
| schin@med.hokudai.ac.jp | |
| Public contact | |
| Name of contact person | Suimon Yuka |
| Organization | Hokkaido University Graduate School of Medicine |
| Division name | Department of Ophthalmology |
| Address | N-15, W-7, Kita-ku, Sapporo, Hokkaido, Japan |
| TEL | 011-706-5944 |
| Homepage URL | |
| suimonyuka@gmail.com | |
| Sponsor | |
| Institute | Department of Ophthalmology Hokkaido university Graduate School of Medicine |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | department of ophthalmology Hokkaido university graduate school of medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024749 |